The Future For CIRM
The New York Times looks at what lies ahead for the California Institute for Regenerative Medicine: "In a nondescript temporary office across the bay from San Francisco, Zach W. Hall is about to lay the groundwork for the largest biomedical venture since the Human Genome Project. With $3 billion committed by the voters of California, his task is to shape the strategy that will best translate the promise of stem cells, which scientists hope will generate novel treatments for many intractable diseases." The article goes on to discuss the high level options, constraints and difficulties for scientific development in the years ahead; a good introduction for people new to the science beneath the debate.
Link: http://www.nytimes.com/2005/10/11/health/policy/11cali.html?pagewanted=print